相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy
Christoph Ehlken et al.
ACTA OPHTHALMOLOGICA (2011)
Characterization of a novel angiogenic model based on stable, fluorescently labelled endothelial cell lines amenable to scale-up for high content screening
Natalie L. Prigozhina et al.
BIOLOGY OF THE CELL (2011)
Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts
Rui Zhang et al.
BIOMATERIALS (2011)
The role of pericytes in angiogenesis
Domenico Ribatti et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2011)
PET image resolution recovery using PSF-based ML-EM deconvolution with blob-based list-mode TOF reconstruction
Bin Zhang et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
In Vivo Small-Animal PET/CT of EphB4 Receptors Using 64Cu-Labeled Peptide
Chiyi Xiong et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Novel EphB4 Monoclonal Antibodies Modulate Angiogenesis and Inhibit Tumor Growth
Valery Krasnoperov et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis
Georg Martiny-Baron et al.
ANGIOGENESIS (2010)
Structure-Activity Relationship Analysis of Peptides Targeting the EphA2 Receptor
Sayantan Mitra et al.
BIOCHEMISTRY (2010)
PEGylation of therapeutic proteins
Simona Jevsevar et al.
BIOTECHNOLOGY JOURNAL (2010)
Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis
Dusan Djokovic et al.
BMC CANCER (2010)
PEGylated polymers for medicine: from conjugation to self-assembled systems
Maisie J. Joralemon et al.
CHEMICAL COMMUNICATIONS (2010)
Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding
Magdalena L. Bochenek et al.
JOURNAL OF CELL SCIENCE (2010)
Endothelial Cells Regulate Cardiomyocyte Development From Embryonic Stem Cells
Kang Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
EphB4 Promotes Site-Specific Metastatic Tumor Cell Dissemination by Interacting with Endothelial Cell-Expressed EphrinB2
Melanie Heroult et al.
MOLECULAR CANCER RESEARCH (2010)
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
Suphansa Sawamiphak et al.
NATURE (2010)
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis
Yingdi Wang et al.
NATURE (2010)
The EphB4 receptor promotes the growth of melanoma cells expressing the ephrin-B2 ligand
Nai-Ying Yang et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Elena B. Pasquale
NATURE REVIEWS CANCER (2010)
PEG conjugates in clinical development or use as anticancer agents: An overview
Gianfranco Pasut et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor
Nicole K. Noren et al.
BIOCHEMICAL JOURNAL (2009)
The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade
Jeffrey S. Scehnet et al.
BLOOD (2009)
EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures
Ombretta Salvucci et al.
BLOOD (2009)
The Receptor Tyrosine Kinase EPHB4 Has Tumor Suppressor Activities in Intestinal Tumorigenesis
Higinio Dopeso et al.
CANCER RESEARCH (2009)
Preferential Induction of EphB4 over EphB2 and Its Implication in Colorectal Cancer Progression
S. Ram Kumar et al.
CANCER RESEARCH (2009)
Emerging PEGylated drugs
Jung Seok Kang et al.
EXPERT OPINION ON EMERGING DRUGS (2009)
Fc-based cytokines - Prospects for engineering superior therapeutics
Jalal A. Jazayeri et al.
BIODRUGS (2008)
The impact of PEGylation on biological therapies
Francesco M. Veronese et al.
BIODRUGS (2008)
Discovering and improving novel peptide therapeutics
Duncan Patrick McGregor
CURRENT OPINION IN PHARMACOLOGY (2008)
FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages
Ulrich Tigges et al.
DEVELOPMENT (2008)
Regulation of angiogenesis by Eph-Ephrin interactions
Sanne Kuijper et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2007)
Paradoxes of the EphB4 receptor in cancer
Nicole K. Noren et al.
CANCER RESEARCH (2007)
The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome
S. R. Kumar et al.
BRITISH JOURNAL OF CANCER (2007)
EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling
Ombretta Salvucci et al.
BLOOD (2006)
The EphB4 receptor-tyrosine kinase promotes the migration of melanoma cells through Rho-mediated actin cytoskeleton reorganization
Nai-Ying Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
Chen Zhao et al.
CELL METABOLISM (2006)
The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth
N Kertesz et al.
BLOOD (2006)
Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression
M Héroult et al.
EXPERIMENTAL CELL RESEARCH (2006)
EphB4 controls blood vascular morphogenesis during postnatal angiogenesis
R Erber et al.
EMBO JOURNAL (2006)
EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival
G Xia et al.
ONCOGENE (2006)
Structure and thermodynamic characterization of the EphB4/ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity
JE Chrencik et al.
STRUCTURE (2006)
Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly
SS Foo et al.
CELL (2006)
Strategies to improve plasma half life time of peptide and protein drugs
M. Werle et al.
AMINO ACIDS (2006)
PEGylation, successful approach to drug delivery
FM Veronese et al.
DRUG DISCOVERY TODAY (2005)
EphB receptor activity suppresses colorectal cancer progression
E Batlle et al.
NATURE (2005)
Up-regulation of EphB4 in mesothelioma and its biological significance
GB Xia et al.
CLINICAL CANCER RESEARCH (2005)
EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity
M Koolpe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth
NK Noren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Phage display-derived peptides as a therapeutic alternatives to antibodies
RC Ladner et al.
DRUG DISCOVERY TODAY (2004)
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
J Oliner et al.
CANCER CELL (2004)
Trypsin cleaves exclusively C-terminal to arginine and lysine residues
JV Olsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
Ephrin receptor, EphB4, regulates ES cell differentiation of primitive mammalian hemangioblasts, blood, cardiomyocytes, and blood vessels
ZY Wang et al.
BLOOD (2004)
Inhibition of tumor growth and angiogenesis by soluble EphB4
G Martiny-Baron et al.
NEOPLASIA (2004)
Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells
T Füller et al.
JOURNAL OF CELL SCIENCE (2003)
Epicardial/mesothelial cell line retains vasculogenic potential of embryonic epicardium
AM Wada et al.
CIRCULATION RESEARCH (2003)
Peptide and protein drug delivery to and into tumors: challenges and solutions
VP Torchilin et al.
DRUG DISCOVERY TODAY (2003)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Role of ephrin B2 in human retinal endothelial cell proliferation and migration
JJ Steinle et al.
CELLULAR SIGNALLING (2003)
Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors
S Morikawa et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo
HJ Lee et al.
BIOCONJUGATE CHEMISTRY (2001)
Reduced antibody response to streptavidin through site-directed mutagenesis
DL Meyer et al.
PROTEIN SCIENCE (2001)
Ephrin-A6, a new ligand for EphA receptors in the developing visual system
P Menzel et al.
DEVELOPMENTAL BIOLOGY (2001)
The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration
RH Adams et al.
CELL (2001)
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization
K Ogawa et al.
ONCOGENE (2000)
Alkaline phosphatase fusions of ligands or receptors as in situ probes for staining of cells, tissues, and embryos
JG Flanagan et al.
APPLICATIONS OF CHIMERIC GENES AND HYBRID PROTEINS PT B (2000)
分享论文
